Guardant Health
GH
#3559
Rank
C$4.18 B
Marketcap
$34.03
Share price
-1.18%
Change (1 day)
-7.87%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -C$0.67 B

According to Guardant Health 's latest financial reports the company's current earnings (TTM) are -C$0.67 B. In 2023 the company made an earning of -C$0.65 B an increase over its 2022 earnings that were of -C$0.89 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.67 B1.74%
2023 -C$0.65 B-26.73%
2022 -C$0.89 B69.96%
2021 -C$0.53 B56.35%
2020 -C$0.34 B252.69%
2019 -C$94.58 M-17.22%
2018 -C$0.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.4 B-40.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$19.41 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA